Zoetis Inc.

Healthcare

NYSE:ZTS · New York Stock Exchange

Market Cap $33.63B Beta 0.74 P/E (TTM) 12.8

$80.22 -1.45%

-$1.18 today

52W Low $72.38High $167.38

Vol 3.59M · Avg 6.03M

EPS (TTM)$6.26

Div Yield2.57%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-51.72%

Period High

$166.23

Period Low

$74.22

Latest

$80.25

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Elevance Health Inc.

NYSE:ELV

$87.54B

Cigna Corporation

NYSE:CI

$78.83B

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

$63.39B

argenx SE

NASDAQ:ARGX

$55.59B

Cencora, Inc.

NYSE:COR

$54.89B

Becton, Dickinson and Company

NYSE:BDX

$52.81B

Takeda Pharmaceutical Company Limited

NYSE:TAK

$50.44B

IDEXX Laboratories, Inc.

NASDAQ:IDXX

$44.14B

Haleon plc

NYSE:HLN

$40.33B

Elanco Animal Health Incorporated

NYSE:ELAN

$12.11B

What is the latest ZTS filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does ZTS have?

Intrinsic Alpha currently shows 20 recent filings for ZTS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.